Imbrium Therapeutics L.P.

CT · United States · Reporting entity ID 100000506821

Total reported 2019–2025

$5.89M

#654 of 2,960 reporting companies — 0% of all reported industry payments

$114K in general payments across 36 records, plus $5.78M in research funding across 303 records.

How it breaks down

General payments $114,041

Research funding $5,776,911

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.